A targeted approach to infectious diseases and microbiology

Size: px
Start display at page:

Download "A targeted approach to infectious diseases and microbiology"

Transcription

1

2 What is a Technological Research Institute? A Technological Research Institute is an interdisciplinary institute bringing together industry and public research skills through medium-to long-term strategic public/private cooperation. A targeted approach to infectious diseases and microbiology Organized by its founders with its own legal statutes as a Foundation for Scientific Cooperation, BIOASTER possesses infrastructures and skills dedicated to: Pilot research programs focused on technology and products Carry out experimental and technological research and development activities Contribute to the development of pre- and post-graduate training programs Conduct socio-economic evaluations of research results. Co-funded by the French State and private partners, it has an independent management team dedicated to: Select, support and manage a portfolio of internal and cooperative R&D projects Develop and manage technical platforms to support projects Create added value from the Industrial Property generated through funded or co-funded projects, in order to become sustainable in the medium to long term. A Technological Research Institute is expected to foster ecosystems composed of competitiveness clusters whose goals are to achieve excellence and contribute to strengthening the competitiveness of the economic sector as a whole, in order to create value and employment. Based in France, BIOASTER s assets include its two major biotech ecosystems located in Lyon (Rhône-Alpes) and Paris (Île-de-France). BIOASTER intends to meet the major public health challenges related to infectious diseases which are responsible for over 17 million deaths worldwide each year: respiratory diseases, diarrheal diseases, AIDS, tuberculosis, malaria, sepsis, etc. Its application fields are anti-infectious drugs, human and animal vaccines, diagnostics and probiotics. BIOASTER is the only health-related Technological Research Institute in France, selected by the General Commission for Investments within the framework of a call for proposals of the Investments for the Future Program. It is dedicated to infectious diseases and microbiology, and tasked with enhancing scientific knowledge, technological know-how and innovation to foster economic development.

3 A NEW KEY PLAYER DRIVEN BY A STRONG ENTREPRENEURIAL DYNAMIC Toward better management of infectious diseases and advances in microbiology One vision Provide a comprehensive and personalized approach to infectious diseases and microbiology. One ambition Establish health firms in the region and foster the emergence of intermediate companies and the growth of small- and mediumsized businesses (SMBs) through a project focused on economic and industrial development. One aim Become a leader in infectious diseases and microbiology research and development. Raising substantial resources Support from the French state within the framework of the Investments for the Future Program Involvement of academic research Commitment of major industrial players A dynamic entrepreneurial network An international Scientific Advisory Board to address scientific issues of the Institute. With all of its partners, BIOASTER will strengthen the role and the international prestige of our country the in field of biology and life sciences. Alain Mérieux - BIOASTER President the fie Bringing together major innovation partners BIOASTER is at a cross-road of know-how and innovation through the meeting of talents. BIOASTER falls today within the scope of a Foundation for Scientific Cooperation and Research, created with public and private funds. BIOASTER gathers 8 founding members: Lyonbiopole and the Institut Pasteur, three major industrial companies - Sanofi, Institut Mérieux, Danone Research - and three academic research centers - INSERM, CNRS, and CEA - as well as a group comprising 40 SMBs (small- and medium-sized businesses) from the Rhône-Alpes and Paris areas. Within the Board of Directors of the Foundation, its founding members sit alongside two representatives from the economic field (including one SMB) and one representative of teachers, researchers and lecturers.

4 2012: BIOASTER set in motion APRIL 19 TH, 2012 Publication of BIOASTER s Foundation for Scientific Cooperation statutes in the Journal officiel de la République française MAY 2 ND, 2012 First BIOASTER s Board of Directors and election of its President, Alain Mérieux FALL 2012 Launch of the first projects and technical platforms Working toward a campus recognized worldwide An ambitious, long-term real estate plan to acquire up to 400,000 sq.ft./35,000 sq.m. New facilities will be built in Lyon-Gerland (France), a main site which will be associated with a second site within the Institut Pasteur in Paris. Two centers of excellence in France will host BIOASTER s technological platforms and research teams Key figures In the first 3 years up to 40 R&D projects to be started with 90 M to be invested by private stakeholders and local authorities Within 9 years, an ambitious prospect More than 700 researchers Up to 400,000 sq.ft./ 35,000 sq.m. of new facilities A cumulative budget of 585 M 180 M in public grants Charles Mérieux Campus in Lyon-Gerland More than 3,000 researchers and skilled scientists in the biotechnology and healthcare sectors 750 researchers and technicians in life sciences International R&D infrastructures such as the Jean Mérieux BSL4 laboratory Global industrial players: Sanofi, Sanofi Pasteur, Merial, Genzyme, Institut Mérieux The Institut Pasteur in Paris 2,600 people 130 research entities organized in 10 thematic departments 14 technological platforms 10 Nobel Prize laureates.

5 A UNIQUE MODEL FOR INNOVATION IN INFECTIOLOGY & MICROBIOLOGY 3 R&D STRUCTURING PROGRAMS 5 TECHNOLOGICAL PLATFORMS Collection and characterization of pathogens New therapies and vaccines Toward real time diagnosis Microbiota: an indicator and a healthcare product Host and host response Biomanufacturing by design Drug and vaccine prototyping technologies New therapeutic, prophylactic and diagnostic products New technologies and high added-value core departments ICT * AND DATA MANAGEMENT A multidisciplinary and innovative approach BIOASTER will conduct its in-house R&D cross-disciplinary activities at the interface of upstream research and industrialization, bridging a missing link to ensure an optimal chain of R&D in infectious diseases and microbiology. BIOASTER brings together complementary industrial and academic players (life sciences, physical, mechanical, chemical, and bioinformatics). Synergies between these players will allow innovative products and new services to enter the market quickly. 3 R&D STUCTURING PROGRAMS 1. New therapies and vaccines The program will focus on developing the following: Antibacterials, antifungals, antiparatics and antivirals, designed around methods that are closer to natural mechanisms, and drawing on the knowledge of interactions between infectious pathogens, cells and hosts New immuno-modulatory treatments made possible by a comprehensive understanding of the host response to infection New vaccines that enable preventive or curative treatment of microorganisminduced illnesses, with lower resistance levels due to the combination of complementary methods New original innovative products can be created by integrating the metabolic approach into the proposed therapeutic strategies Personalized methodology for the treatment and prevention of infectious diseases. 2. Toward real time diagnosis The aim of this program is to develop new diagnostics making it possible to predict infections and identify pathogen(s) rapidly. This enables personalized management against infections and immediate prescription of the adapted treatments. 3. Microbiota: an indicator and a healthcare product The aim of this program is to advance the scientific concepts of predictive microbiota (indicator of health, homeostasis) and therapeutic microbiota (probiotics) in order to develop new varieties of diagnostic, therapeutic, and preventive products. It fully integrates into an approach toward preventive medicine and nutrition. 5 TECHNOLOGICAL PLATFORMS The implementation of R&D programs will rely on five high-level platforms offering: Competencies and infrastructural equipment to help develop state-ofthe-art technologies Services provided with SMBs Development of R&D projects with an emphasis on technology. BIOASTER will set up a structure dedicated to deriving the maximum benefit from research results, patents and products developed within the Institute. * Information and Communication Technologies

6 JOIN BIOASTER: A WINNING FORMULA TO STRENGTHEN YOUR COMPETITIVENESS BIOASTER represents a strong link in the chain of innovation in infectious diseases and microbiology: an exclusive opportunity to co-invest in completely new approaches, to share risk among industrials, SMBs, and academic organizations, and to utilize technical resources and complementary skills that support your activities. Becoming part of a dynamic network of SMBs What sets BIOASTER apart and makes it particularly promising is the fact that it involves some forty SMBs from the Rhône-Alpes and Paris regions. BIOASTER can offer SMBs: High-level technical facilities Enhanced expertise by sharing with all partners Assistance in developing new services Access to a larger portfolio of collaborative ventures Growth opportunities to become a medium-sized company Further promotion and greater international recognition Greater research volumes and services Privileged access to innovation and breakthrough technologies Over time, stronger economic growth. Anchoring major industrial companies in the area The strong involvement of major French companies engaged in infectious diseases and microbiology research (Sanofi, Sanofi Pasteur, biomérieux, Merial, Danone Research ) demonstrates the value of BIOASTER s project, which will provide: A single source of skills, expertise and resources Techniques in their field of activity to accelerate the development of innovative products and strengthen their industrial sectors Large engineering and international facilities Access to top-level academic resources Strong incentives to attract international companies seeking to further their economic and industrial significance in the area Leading-edge technical services. Creating value together BIOASTER has a positive knock-on effect on the level of resources and knowledge from the early research stage through product development, due to: Multidisciplinary skills and state-of-the-art facilities Risk sharing and expansion of scientific approaches related to projects New technological and industrial opportunities Advancement for economic growth and jobs creation Cross-sector and interdisciplinary research approaches.

7 TECHNOLOGICAL RESEARCH INSTITUTE CONTACT BIOASTER - Bâtiment Domilyon 321, avenue Jean-Jaurès Lyon FRANCE Tel: +33 (0) FOUNDERS SUPPORTED BY LOCAL AUTHORITIES / THERA Conseil / RCS Lyon B / Photos: Sanofi Institut Mérieux: C. Ganet, L. Bouchut, S. Audras GraphicObsession Getty Images Fotolia IRT BIOASTER aerial view Asylum for Grand Lyon.

Editorial. Yves Levy, Executive Director

Editorial. Yves Levy, Executive Director Editorial Yves Levy, Executive Director I am delighted to announce the creation of a new research centre: the Vaccine Research Institute (VRI). The VRI addresses the unprecedented challenge of developing

More information

THE STRENGTH OF THE ONCOPOLE, a radically new pooling of expertise

THE STRENGTH OF THE ONCOPOLE, a radically new pooling of expertise TRAINING + RESEARCH + HEALTHCARE + INDUSTRY : THIS IS THE ONCOPOLE. THE STRENGTH OF THE ONCOPOLE, a radically new pooling of expertise The Oncopole is the only site in Europe that brings together both

More information

RECOMMEND APPROVAL OF MASTER OF SCIENCE IN BIOMEDICAL SCIENCE AND BIOTECHNOLOGY AT UNIVERSITY OF COLORADO DENVER

RECOMMEND APPROVAL OF MASTER OF SCIENCE IN BIOMEDICAL SCIENCE AND BIOTECHNOLOGY AT UNIVERSITY OF COLORADO DENVER Page 1 of 5 TOPIC: PREPARED BY: RECOMMEND APPROVAL OF MASTER OF SCIENCE IN BIOMEDICAL SCIENCE AND BIOTECHNOLOGY AT UNIVERSITY OF COLORADO DENVER IAN MACGILLIVRAY, DIRECTOR OF ACADEMIC AFFAIRS I. SUMMARY

More information

Career Opportunities within the French Alliance for Life and Health Sciences

Career Opportunities within the French Alliance for Life and Health Sciences 1 Career Opportunities within the French Alliance for Life and Health Sciences Mireille Guyader, PhD Director, Inserm-USA Office INSERM KEY FIGURES (Year 2013) Budget: 970 M (~ $1.2 Billion) Human resources:

More information

FACULTY OF MEDICAL SCIENCE

FACULTY OF MEDICAL SCIENCE Doctor of Philosophy Program in Microbiology FACULTY OF MEDICAL SCIENCE Naresuan University 171 Doctor of Philosophy Program in Microbiology The time is critical now for graduate education and research

More information

The European Innovation Council A New Framework for EU Innovation Policy

The European Innovation Council A New Framework for EU Innovation Policy The European Innovation Council A New Framework for EU Innovation Policy EARTO recommendations to the European Commission to initiate further discussion 9 October 2015 Introduction: EIC as a Key Action

More information

Join our scientific talent community

Join our scientific talent community Join our scientific talent community There has never been a better time to be a part of Janssen Research & Development. We are at the forefront of healthcare leading, evolving and transforming it into

More information

Identification of a problem, e.g., an outbreak Surveilance Intervention Effect

Identification of a problem, e.g., an outbreak Surveilance Intervention Effect EPIDEMIOLOGY EPIDEMIOLOGY Epidemiology is a cornerstone of the control of infectious diseases. Statens Serum Institut s epidemiological activities cover a wide field, from surveillance of diseases and

More information

Professional Science Masters Degrees. What are PSM degrees?

Professional Science Masters Degrees. What are PSM degrees? Professional Science Masters Degrees Charles E. Schmidt College of Science Presentation to FAU Board of Trustees April 21, 2010 by Dean Gary W. Perry What are PSM degrees? Professional Science Master programs

More information

PX Therapeutics : the partner for early stage biotherapeutics development Biotuesday, May 5 2009

PX Therapeutics : the partner for early stage biotherapeutics development Biotuesday, May 5 2009 PX Therapeutics : the partner for early stage biotherapeutics development Biotuesday, May 5 2009 Christelle Dagoneau, PhD Business Development Director Company Profile Protein expert incorporated in 2000

More information

Legislative Council Secretariat FACT SHEET. Pharmaceutical industry in Denmark

Legislative Council Secretariat FACT SHEET. Pharmaceutical industry in Denmark FACT SHEET Pharmaceutical industry in Denmark 1. Introduction 1.1 The Danish pharmaceutical industry is known worldwide for providing quality drugs and medical products. In 2012, Denmark was the 16 th

More information

Choosing France. Excellence of French. Research and Innovation, Universities and Schools. Marc ROUSSET Attaché for Science and Technology

Choosing France. Excellence of French. Research and Innovation, Universities and Schools. Marc ROUSSET Attaché for Science and Technology Choosing France Excellence of French Research and Innovation, Universities and Schools Marc ROUSSET Attaché for Science and Technology POLICY AGENCIES / PROGRAMS RESEARCH AND R&D PLAYERS Organization of

More information

Understand life - Preserve the environment. Strategy Document, Department of Biology 2015 2020

Understand life - Preserve the environment. Strategy Document, Department of Biology 2015 2020 Understand life - Preserve the environment Strategy Document, Department of Biology 2015 2020 1 2 Photo: Per Harald Olsen/NTNU Understand life - Preserve the environment Strategy Document for the Department

More information

HCERES report on research unit: Under the supervision of the following institutions and research bodies: Department of immunology

HCERES report on research unit: Under the supervision of the following institutions and research bodies: Department of immunology Research units HCERES report on research unit: Department of immunology Under the supervision of the following institutions and research bodies: Institut Pasteur Paris Institut National de la Santé Et

More information

Turku School of Economics: Strategy for 2010 2015

Turku School of Economics: Strategy for 2010 2015 Turku School of Economics: Strategy for 2010 2015 Appendix A TURKU SCHOOL OF ECONOMICS STRATEGY FOR 2010 2015 1 The strategic position of the Turku School of Economics... 1 1.1 Operating environment...

More information

Creating the Future Pierre and Marie Curie University. www.upmc.fr

Creating the Future Pierre and Marie Curie University. www.upmc.fr Creating the Future Pierre and Marie Curie University www.upmc.fr UPMC: the Leading French Scientific and Medical University Every day, UPMC demonstrates how education and research create important synergies.

More information

Degrees in Science (& Physics)

Degrees in Science (& Physics) Degrees in Science (& Physics) NUI, Galway College of Science National University of Ireland, Galway Revised January 2008 3 The world has changed...it has become FLAT! Geography no longer matters. Three

More information

The Healthy Asia Pacific 2020 Roadmap INTRODUCTION: THE HEALTHY ASIA PACIFIC 2020 INITIATIVE

The Healthy Asia Pacific 2020 Roadmap INTRODUCTION: THE HEALTHY ASIA PACIFIC 2020 INITIATIVE The Healthy Asia Pacific 2020 Roadmap INTRODUCTION: THE HEALTHY ASIA PACIFIC 2020 INITIATIVE In the 2014 APEC Leader s Declaration and Joint Ministerial Statement, it is recognized that the prospect of

More information

draft Roadmap initiative Investment in Basic and Applied Science and Engineering

draft Roadmap initiative Investment in Basic and Applied Science and Engineering Initial Charge draft Roadmap initiative Investment in Basic and Applied Science and Engineering SUMMARY The University of Miami s achievements and excellence in the basic sciences, applied sciences, and

More information

Epidemics emergency: what role for research?

Epidemics emergency: what role for research? Epidemics emergency: what role for research? Pr Jean François Delfraissy Dr Bernadette Murgue Institut of Microbiology & Infectious Diseases 1 The Heavy Burden of Infectious Diseases Infectious diseases

More information

VENTURE TECHNOLOGY MASTER S PROGRAM TECHNOLOGY INNOVATION AND ENTREPRENEURSHIP

VENTURE TECHNOLOGY MASTER S PROGRAM TECHNOLOGY INNOVATION AND ENTREPRENEURSHIP TECHNOLOGY VENTURE MASTER S PROGRAM AT THE INTERSECTION OF TECHNOLOGY INNOVATION AND ENTREPRENEURSHIP AN IDEAL ENVIRONMENT FOR GROWING STARTUPS: MENTORSHIP EDUCATION ENTREPRENEURIAL PROJECTS A UNIQUE CAMPUS

More information

State Aid for Research, Development and Innovation for the Benefit of Luxembourg s Economy

State Aid for Research, Development and Innovation for the Benefit of Luxembourg s Economy State Aid for Research, Development and Innovation for the Benefit of Luxembourg s Economy Law of 5 June 2009 relating to the promotion of research, development and innovation CONTENTS Editorials 03 The

More information

Il ruolo dell Advisory Group for «Health, Wellbeing and Demographic Change» in Horizon 2020

Il ruolo dell Advisory Group for «Health, Wellbeing and Demographic Change» in Horizon 2020 Il ruolo dell Advisory Group for «Health, Wellbeing and Demographic Change» in Horizon 2020 Lucia Monaco Horizon 2020 Advisory Group, Societal Challenges 1: Health, Demographic Change and Wellbeing Seminario:

More information

THE LINCOLN INSTITUTE OF HEALTH

THE LINCOLN INSTITUTE OF HEALTH THE LINCOLN INSTITUTE OF HEALTH Background The Chair in the Care of the Older Person will be part of the new Lincoln Institute of Health, a cross disciplinary research collaboration linking schools, colleges

More information

Moving an HIV Vaccine from Lab to Clinic: The Importance of Industry Engagement

Moving an HIV Vaccine from Lab to Clinic: The Importance of Industry Engagement Canadian HIV Vaccine Initiative (CHVI) Research and Development Alliance Coordinating Office (ACO) Annual Meeting 2013: Moving an HIV Vaccine from Lab to Clinic: The Importance of Industry Engagement Executive

More information

NMBP calls in 2015. Leadership in Enabling and Industrial Technologies Work Programme 2014-15

NMBP calls in 2015. Leadership in Enabling and Industrial Technologies Work Programme 2014-15 NMBP calls in 2015 Leadership in Enabling and Industrial Technologies Work Programme 2014-15 Nicholas Deliyanakis Deputy Head of Unit Strategy Key Enabling Technologies DG Research and European Commission

More information

Molecular Biotechnology Master s Degree Program

Molecular Biotechnology Master s Degree Program > APPLIED LIFE SCIENCES Master s Degree Program: > FULL TIME Molecular Biotechnology Master s Degree Program www.fh-campuswien.ac.at My Occupational Future. Your Career Opportunities Biotechnology is one

More information

RN to BSN. Course Descriptions

RN to BSN. Course Descriptions RN to BSN Course Descriptions CGN 100 English Composition This course is designed to teach the student and prepare them for college writing. Students will compose essays and other works using various methods

More information

2009 Foley & Lardner LLP Attorney Advertising Prior results do not guarantee a similar outcome Models used are not clients but may be representative

2009 Foley & Lardner LLP Attorney Advertising Prior results do not guarantee a similar outcome Models used are not clients but may be representative Attorney Advertising Prior results do not guarantee a similar outcome Models used are not clients but may be representative of clients 321 N. Clark Street, Suite 2800, Chicago, IL 60654 312.832.4500 Life

More information

Future and Emerging Technologies (FET) in H2020. Ales Fiala Future and Emerging Technologies DG CONNECT European Commission

Future and Emerging Technologies (FET) in H2020. Ales Fiala Future and Emerging Technologies DG CONNECT European Commission Future and Emerging Technologies (FET) in H2020 51214 Ales Fiala Future and Emerging Technologies DG CONNECT European Commission H2020, three pillars Societal challenges Excellent science FET Industrial

More information

International training programme

International training programme International training programme Science has no native land, as knowledge is the heritage of humankind, the torch that lights up the world. Louis Pasteur The Institut Pasteur International Network (RIIP)

More information

Curriculum Vitae. Education. Brief Chronology of Employment. Academic Positions held. Pier Paolo Di Fiore M.D. Ph.D.

Curriculum Vitae. Education. Brief Chronology of Employment. Academic Positions held. Pier Paolo Di Fiore M.D. Ph.D. Pier Paolo Di Fiore M.D. Ph.D. Curriculum Vitae Education 1981 - M.D., summa cum laude, University of Naples, 2nd Medical School, Naples, Italy 1984 - Board in Oncology, summa cum laude, University of

More information

MSc/PGD/PGC in Infection (part-time)

MSc/PGD/PGC in Infection (part-time) MSc/PGD/PGC in Infection (part-time) Course Brochure Course highlights The MSc/PGD/PGC in Infection is aimed at health care professionals across the globe with an interest in infection prevention and infectious

More information

The NIH Roadmap: Re-Engineering the Clinical Research Enterprise

The NIH Roadmap: Re-Engineering the Clinical Research Enterprise NIH BACKGROUNDER National Institutes of Health The NIH Roadmap: Re-Engineering the Clinical Research Enterprise Clinical research is the linchpin of the nation s biomedical research enterprise. Before

More information

Bachelor of Health Sciences

Bachelor of Health Sciences Bachelor of Health Sciences ABOUT THE PROGRAMME DURING THE PROGRAMME CORE CURRICULUM ENTRY REQUIREMENTS Our programme trains and develops professionals (apart from physicians) who want to establish careers

More information

2014 Report: biotechnologies in the Italian pharmaceutical sector

2014 Report: biotechnologies in the Italian pharmaceutical sector 2014 Report: biotechnologies in the Italian pharmaceutical sector In collaboration with Assobiotec Executive summary Executive summary Executive summary Biotechnologies have always influenced all spheres

More information

HCERES report on research unit:

HCERES report on research unit: Research units HCERES report on research unit: Translational Gene Therapy for neuromuscular and retinal diseases Under the supervision of the following institutions and research bodies: Université de Nantes

More information

ZENTIVA A SANOFI COMPANY. Corporate Presentation

ZENTIVA A SANOFI COMPANY. Corporate Presentation ZENTIVA A SANOFI COMPANY Corporate Presentation SANOFI A global healthcare leader, focused on patients needs SANOFI A global integrated healthcare leader, focused on patients needs CORPORATE PRESENTATION

More information

FET-Open in Horizon2020 Work Programme 2014-2015. Roumen Borissov Future and Emerging Technologies FET-Open Research Executive Agency

FET-Open in Horizon2020 Work Programme 2014-2015. Roumen Borissov Future and Emerging Technologies FET-Open Research Executive Agency FET-Open in Horizon2020 Work Programme 2014-2015 Roumen Borissov Future and Emerging Technologies FET-Open Research Executive Agency Content Future and Emerging Technologies (FET) in Horizon 2020 FET-Open

More information

UNCOVERING OPPORTUNITIES IN THE BIOTECH SECTOR - BRAZIL

UNCOVERING OPPORTUNITIES IN THE BIOTECH SECTOR - BRAZIL UNCOVERING OPPORTUNITIES IN THE BIOTECH SECTOR - BRAZIL INTRODUCTION BY INNOVATION CENTRE DENMARK IN SAO PAULO BRAZILIAN BIOTECHNOLOGY SECTOR The Ministry of Science, Technology and Innovation (MCTI) considers

More information

Introduction. 1. General outline. 1) Position of the Healthcare Policy. 2) Basic principles of the Healthcare Policy (Article 2 of the Promotion Act)

Introduction. 1. General outline. 1) Position of the Healthcare Policy. 2) Basic principles of the Healthcare Policy (Article 2 of the Promotion Act) Overview of the Healthcare Policy Introduction For Japan, which is becoming an ultra-aging society ahead of other countries, it is important to realize the world s most advanced medical technologies and

More information

Poxel Raises 16 million in a Series A Financing to Accelerate Pipeline Development

Poxel Raises 16 million in a Series A Financing to Accelerate Pipeline Development Poxel Raises 16 million in a Series A Financing to Accelerate Pipeline Development Lyon, France, July 8, 2010 -, a diabetes drug development specialist, announces today that it has raised 16 million (USD

More information

Health Innovation. Innovation for health includes the. diagnostics and medical devices, as

Health Innovation. Innovation for health includes the. diagnostics and medical devices, as BIO-INNOVATION Health Innovation Innovation for health includes the development of new drugs, vaccines, diagnostics and medical devices, as well as new techniques in process engineering and manufacturing,

More information

Board of Member States ERN implementation strategies

Board of Member States ERN implementation strategies Board of Member States ERN implementation strategies January 2016 As a result of discussions at the Board of Member States (BoMS) meeting in Lisbon on 7 October 2015, the BoMS set up a Strategy Working

More information

Graduate School of Excellence Exzellenz-Graduiertenschule

Graduate School of Excellence Exzellenz-Graduiertenschule Jena School for Microbial Communication Graduate School of Excellence Exzellenz-Graduiertenschule Microbial Communication Talking Microbes? Microorganisms are present everywhere. They are often considered

More information

Future and Emerging Technologies (FET) FET-Open in Work Programme 2014-2015 in H2020

Future and Emerging Technologies (FET) FET-Open in Work Programme 2014-2015 in H2020 Future and Emerging Technologies (FET) FET-Open in Work Programme 2014-2015 in H2020 51214 FET 2014 Info Session 28 May 2014 Walter Van de Velde Future and Emerging Technologies European Commission the

More information

The Brussels Enterprise Agency & BEA Innovative Sectors dpt.

The Brussels Enterprise Agency & BEA Innovative Sectors dpt. The Brussels Enterprise Agency & BEA Innovative Sectors dpt. The Brussels Enterprise Agency Outline BEA Innovative Sectors Department at a glance The Brussels Enterprise Agency (BEA) Regional development

More information

Oportunidades no 7.º Programa-Quadro e no Horizonte 2020 para o setor da Saúde. Sessão de apresentação do ProjetoDo IT

Oportunidades no 7.º Programa-Quadro e no Horizonte 2020 para o setor da Saúde. Sessão de apresentação do ProjetoDo IT Oportunidades no 7.º Programa-Quadro e no Horizonte 2020 para o setor da Saúde Vision Mission Flagship Initiative Innovation Union Europe 2020 (Mar 2010) 6 other Flagships Structural Funds Strategy FP7

More information

The Nature of Biology

The Nature of Biology The Nature of Science Science is an ongoing, human, cultural activity which involves the efforts of many people to describe the world in mutually acceptable terms. Scientific knowledge is the cumulative

More information

Masters Learning mode (Форма обучения)

Masters Learning mode (Форма обучения) Program Title (Название программы): Pharmacology Degree (Степень) Masters Learning mode (Форма обучения) Full-time and part-time Duration of study (Продолжительность программы) 2 years (4 years part time)

More information

A Private Investor Guide to Regenerative Medicine: Unique Opportunities in an Emerging Field

A Private Investor Guide to Regenerative Medicine: Unique Opportunities in an Emerging Field A Private Investor Guide to Regenerative Medicine: Unique Opportunities in an Emerging Field Introduction The field of regenerative medicine remains at the forefront of personalized medicine and healthcare

More information

Job list - Research China

Job list - Research China Job list - Research China Job # Job Title Page 010499 Scientist for Mechanical Engineering P2-3 002590 Senior Scientist for Biomedical Engineering P4-5 022831 Research Scientist for MRI P6-7 010501 Scientist

More information

HealthBIO in Helsinki Region 2008 BioSA Workshops in South Africa, 31.3 2.4.2008

HealthBIO in Helsinki Region 2008 BioSA Workshops in South Africa, 31.3 2.4.2008 HealthBIO in Helsinki Region 2008 BioSA Workshops in South Africa, 31.3 2.4.2008 Riikka Paasikivi Program Director Culminatum Ltd Oy Helsinki, Finland Helsinki Region Over 1.2 million inhabitants (population

More information

Public private partnership research cooperation

Public private partnership research cooperation Public private partnership research cooperation 2012 Eu SPRI Conference Towards Transformative Governance? -Responses to missionoriented innovation policy paradigms Karlsruhe 2012 Dr. Dirk Meissner Deputy

More information

Grow your business via Västerbotten. Regional Partner

Grow your business via Västerbotten. Regional Partner Grow your business via Västerbotten Anti-infective research in Umeå Unique insight on the pathogenicity of microbes and novel approaches on antibiotics 3 universities with 35.000 students (Umeå University

More information

GEOSYSTEMS RESEARCH INSTITUTE at Mississippi State University A STRATEGIC PLAN FOR PROGRAM EXCELLENCE

GEOSYSTEMS RESEARCH INSTITUTE at Mississippi State University A STRATEGIC PLAN FOR PROGRAM EXCELLENCE GEOSYSTEMS RESEARCH INSTITUTE at Mississippi State University A STRATEGIC PLAN FOR PROGRAM EXCELLENCE 2009-2013 GRI Strategic Plan Page 2 The Geosystems Research Institute (GRI) engages faculty from across

More information

Increasing Innovation in R&D - Seizing early stage external growth opportunities

Increasing Innovation in R&D - Seizing early stage external growth opportunities Increasing Innovation in R&D - Seizing early stage external growth opportunities Paul R. Eynott, PhD sanofi-aventis, US paul.eynott@sanofi-aventis.com -1- Sommaire -2- CHRISTOPHER A. VIEHBACHER Chief Executive

More information

www.univ-paris-est.fr A POLE OF RESEARCH AND HIGHER EDUCATION (PRES)

www.univ-paris-est.fr A POLE OF RESEARCH AND HIGHER EDUCATION (PRES) www.univ-paris-est.fr A POLE OF RESEARCH AND HIGHER EDUCATION (PRES) Pole of research and higher education 16 universities, schools, grandes écoles, research institutes and competitiveness cluster members

More information

Vaccines Researches for the Future:

Vaccines Researches for the Future: ITMO Microbiologie et maladies infectieuses Vaccines Researches for the Future: The corevac initiative Pr Brigitte AUTRAN Institute Infection-Cancer-Immunity, UPMC, Paris Pr Jean François Delfraissy Institute

More information

Anti-infective research in Umeå. Regional Partner

Anti-infective research in Umeå. Regional Partner Anti-infective research in Umeå Unique insight on pathogenicity of microbes and novel approaches on antibiotics 3 universities with 35.000 students (Umeå University www.umu.se, Luleå Technical University

More information

The Biotech Business Life Cycle. The Lawyer s Role as Counselor and Advisor

The Biotech Business Life Cycle. The Lawyer s Role as Counselor and Advisor The Biotech Business Life Cycle and The Lawyer s Role as Counselor and Advisor ASU February 15, 2010 1 BIOTECH BUSINESS CYCLE AN INTERDISCIPLINARY APPROACH TO LEGAL REPRESENTATION Intellectual Property

More information

Centrale-Santé: The Professional Healthcare and biotech Think Tank Professional Group Centrale Alumni Association

Centrale-Santé: The Professional Healthcare and biotech Think Tank Professional Group Centrale Alumni Association Centrale-Santé: The Professional Healthcare and biotech Think Tank Professional Group Centrale Alumni Association Centrale-Santé Presentation 2010 www.centrale-sante.net 1 Centrale-Santé at a glance The

More information

Childhood at your fingertips

Childhood at your fingertips Childhood at your fingertips The Encyclopedia on Early Childhood Development is the leading resource of the best and most up-to-date knowledge available on the development of young children. LEADING-EDGE

More information

La E.I.P. «Agricultural Productivity and Sustainability: il coinvolgimento delle imprese chimiche

La E.I.P. «Agricultural Productivity and Sustainability: il coinvolgimento delle imprese chimiche La E.I.P. «Agricultural Productivity and Sustainability: il coinvolgimento delle imprese chimiche PARCO TECNOLOGICO PADANO Simona Palermo - Project Manager Lodi innovation Cluster Parco Tecnologico Padano

More information

DEPARTMENT OF SCIENCE & TECHNOLOGY CHANDIGARH ADMINISTRATION

DEPARTMENT OF SCIENCE & TECHNOLOGY CHANDIGARH ADMINISTRATION BIO Technology Policy: DEPARTMENT OF SCIENCE & TECHNOLOGY CHANDIGARH ADMINISTRATION INTRODUCTION: Biotechnology is defined as the controlled use of biological agents, i.e. micro organisms or cellular components,

More information

Accreditation of Master of Pharmacy Degrees

Accreditation of Master of Pharmacy Degrees Accreditation of Master of Pharmacy Degrees Interim standards, Sept 2010 Introduction This document sets out the standards against which we, the General Pharmaceutical Council (GPhC), will accredit those

More information

Biotechnology Current Trends

Biotechnology Current Trends Biotechnology Current Trends Biotechnology Key Trends - Higher growth will be continued on Biotechnology sector during the next four years, around 14% annually. - Asia pacific countries are the most promising

More information

EVALUATION GUIDELINES

EVALUATION GUIDELINES EVALUATION GUIDELINES Introduction This document outlines the reviewing process and defines the responsibilities of the participants in the process. It details a number of important issues, such as: FCT

More information

The Cell Therapy Catapult

The Cell Therapy Catapult The Cell Therapy Catapult Keith Thompson CEO January 29 2013 info@ct.catapult.org.uk Catapult is a Technology Strategy Board programme The Launch of Catapults Hauser 2 Hauser Report Creating new manufacturing

More information

Anforderungen der Life-Science Industrie an die Hochschulen. Hans Widmer Novartis Institutes for BioMedical Research

Anforderungen der Life-Science Industrie an die Hochschulen. Hans Widmer Novartis Institutes for BioMedical Research Anforderungen der Life-Science Industrie an die Hochschulen Hans Widmer Novartis Institutes for BioMedical Research There s nothing more extraordinary than a normal life 2 What does industry expect from

More information

Open Innovation: An Imperative for the Pharmaceutical Industry. Berkeley Innovation Forum

Open Innovation: An Imperative for the Pharmaceutical Industry. Berkeley Innovation Forum Open Innovation: An Imperative for the Pharmaceutical Industry Berkeley Innovation Forum October 28-29, 2010 Minneapolis, MN Ted Torphy, Ph.D. Vice President & Head External Innovation Research Capabilities

More information

Boston University Metropolitan College/ School of Medicine Biomedical Laboratory and Clinical Sciences (BLCS) Strategic Plan Outline

Boston University Metropolitan College/ School of Medicine Biomedical Laboratory and Clinical Sciences (BLCS) Strategic Plan Outline Boston University Metropolitan College/ School of Medicine Biomedical Laboratory and Clinical Sciences (BLCS) Strategic Plan Outline 1. The Biomedical Laboratory and Clinical Sciences program, a joint

More information

INVENTORY OF GOOD PRACTICES ON OPEN INNOVATION Business Angels Region Stuttgart

INVENTORY OF GOOD PRACTICES ON OPEN INNOVATION Business Angels Region Stuttgart INVENTORY OF GOOD PRACTICES ON OPEN INNOVATION Business Angels Region Stuttgart Stuttgart Region, Germany Table of contents 1. Good Practice Profile... 3 2. Good Practice General Description... 6 3. Good

More information

Medical & Health Sciences

Medical & Health Sciences School of Postgraduate Studies Medical & Health Sciences (MSc /PhD by Research) 2016 What Is IMU s Medical & Health Sciences (by Research) Programme About? Overview Postgraduate research forms a major

More information

Profile of Biomedical Research and Biotechnology Commercialization. Boston-Worcester-Lawrence Consolidated Metropolitan Statistical Area

Profile of Biomedical Research and Biotechnology Commercialization. Boston-Worcester-Lawrence Consolidated Metropolitan Statistical Area Profile of Biomedical Research and Biotechnology Commercialization Boston-Worcester-Lawrence Consolidated Metropolitan Statistical Area Overview and History of Biotechnology in Boston Along with San Francisco,

More information

The University of Texas at Austin - Portugal An international partnership in graduate education, research, and technology commercialization

The University of Texas at Austin - Portugal An international partnership in graduate education, research, and technology commercialization The University of Texas at Austin - Portugal An international partnership in graduate education, research, and technology commercialization Technical Appendix to the Memorandum of Understanding toward

More information

Georgia Department of Education Career Pathway Descriptions

Georgia Department of Education Career Pathway Descriptions Health Science Cluster Planning, managing, and providing therapeutic services, diagnostic services, health informatics, support services, and biotechnology research and development. Diagnostic Services

More information

Science for a healthy society. Food Safety Centre. Food Databanks. Food & Health. Industrial Biotechnology. Gut Health

Science for a healthy society. Food Safety Centre. Food Databanks. Food & Health. Industrial Biotechnology. Gut Health Food Safety Centre Food Databanks Food & Health Industrial Biotechnology National Collection of Yeast Cultures Gut Health Science for a healthy society A recent independent report has quantified the economic

More information

A Degree in Science is:

A Degree in Science is: A Degree in Science is: Intellectually stimulating Can lead to a variety of careers: Scientific Research (with opportunities for working with animals) Teaching Science-related jobs Advisory Sales Patents..

More information

Professor of Food, Nutrition and Dietetics. SUPERVISOR: Professor Gregory Blatch / Dean, College of Health and Biomedicine APPROVED BY:

Professor of Food, Nutrition and Dietetics. SUPERVISOR: Professor Gregory Blatch / Dean, College of Health and Biomedicine APPROVED BY: POSITION TITLE: Professor of Food, Nutrition and Dietetics POSITION NUMBER: 908871 COLLEGE/ DEPARTMENT: College of Health and Biomedicine LOCATION/CAMPUS: CLASSIFICATION: St Albans Level E SUPERVISOR:

More information

What if there are no new antibiotics? Alternatives to Antibiotics

What if there are no new antibiotics? Alternatives to Antibiotics What if there are no new antibiotics? Highlights of a Wellcome Trust & Department of Health (England) initiated & sponsored review & report into Alternatives to Antibiotics STOA EuCheMS 28 April 2016 European

More information

Association. Colleges. 1 Science, ACCC is of all ages. supplying. graduates support. Over the Canada s recognizes. (2008 09 sector and

Association. Colleges. 1 Science, ACCC is of all ages. supplying. graduates support. Over the Canada s recognizes. (2008 09 sector and Association of Canadian Community Colleges Submission to the Government of Canada s Sciencee and Technology Consultation February 7, 2014 The Association of Canadian Community Colleges (ACCC) appreciates

More information

Rutgers Mini-MBA : BioPharma Innovation

Rutgers Mini-MBA : BioPharma Innovation Rutgers Mini-MBA : BioPharma Innovation Ga i n t h e s k i l l s to t r a n s f o r m scientific i n n ovat i o n i n to business success www.cmd.rutgers.edu/innovation Rutgers Mini-MBA : BioPharma Innovation

More information

Programme «Allocations de recherche pour une thèse au Sud (ARTS)» ARTS program

Programme «Allocations de recherche pour une thèse au Sud (ARTS)» ARTS program Programme «Allocations de recherche pour une thèse au Sud (ARTS)» ARTS program Call for proposals 2015 Non thematical ARTS call Thematical ARTS call Fondation MERIEUX : Infectious diseases IN2P3 (CNRS)

More information

Introduction to Microbiology The Microbial World and You (Chapter 1) Lecture Materials for Amy Warenda Czura, Ph.D. Suffolk County Community College

Introduction to Microbiology The Microbial World and You (Chapter 1) Lecture Materials for Amy Warenda Czura, Ph.D. Suffolk County Community College Introduction to Microbiology The Microbial World and You (Chapter 1) Lecture Materials for Amy Warenda Czura, Ph.D. Suffolk County Community College Primary Source for figures and content: Eastern Campus

More information

Profile of Biomedical Research and Biotechnology Commercialization. San Francisco Oakland San Jose Consolidated Metropolitan Statistical Area

Profile of Biomedical Research and Biotechnology Commercialization. San Francisco Oakland San Jose Consolidated Metropolitan Statistical Area Profile of Biomedical Research and Biotechnology Commercialization San Oakland San Jose Consolidated Metropolitan Statistical Area Overview and History of Biotechnology in San The San Bay area is in many

More information

A WORLD-CLASS HIGHER EDUCATION AND RESEARCH ESTABLISHMENT

A WORLD-CLASS HIGHER EDUCATION AND RESEARCH ESTABLISHMENT A WORLD-CLASS HIGHER EDUCATION AND RESEARCH ESTABLISHMENT TRAINING FUTURE LEADERS ÉCOLE POLYTECHNIQUE PRODUCES SOCIALLY RESPONSIBLE PROFESSIONALS WHO EXCEL IN HIGH-LEVEL KEY POSITIONS AND LEAD COMPLEX

More information

I M HEALING SKIN WITH LIGHT

I M HEALING SKIN WITH LIGHT GRADUATE SCHOOL 2015-2016 I M HEALING SKIN WITH LIGHT Graduate program LIFE SCIENCES AND ENGINEERING * This major is formally part of the Computer Science & Engineering Bachelor program Graduate program

More information

The European CYberSecurity cppp ECYS Draft Proposal

The European CYberSecurity cppp ECYS Draft Proposal The European CYberSecurity cppp ECYS Draft Proposal 12 April 2016 The urgency to act We cannot miss the window opportunity for budgetary reasons: create a synergy among the different EC budgets via the

More information

Workprogramme 2014-15

Workprogramme 2014-15 Workprogramme 2014-15 e-infrastructures DCH-RP final conference 22 September 2014 Wim Jansen einfrastructure DG CONNECT European Commission DEVELOPMENT AND DEPLOYMENT OF E-INFRASTRUCTURES AND SERVICES

More information

BIOVISION 2015 CATALYZER & INVESTOR CONFERENCE

BIOVISION 2015 CATALYZER & INVESTOR CONFERENCE Co-organized with: Lyon - France April 15 & 16, 2015 fond blanc fond vert fond noir Call for pitches BIOVISION 2015 CATALYZER & INVESTOR CONFERENCE Organized by in collaboration with LA MÉTROPOLE BIOVISION

More information

Parliamentary Intergroup on Animal Welfare and Conservation of Animals. European Parliament, Strasbourg, 23 May 2013

Parliamentary Intergroup on Animal Welfare and Conservation of Animals. European Parliament, Strasbourg, 23 May 2013 Parliamentary Intergroup on Animal Welfare and Conservation of Animals European Parliament, Strasbourg, 23 May 2013 At a glance A Public-Private Partnership launched in 2005 36 COMPANIES 7 SECTORS OF ACTIVITY

More information

Legislative Council Panel on Commerce and Industry. 2016 Policy Address Policy Initiatives of Innovation and Technology Bureau

Legislative Council Panel on Commerce and Industry. 2016 Policy Address Policy Initiatives of Innovation and Technology Bureau LC Paper No. CB(1)436/15-16(05) Legislative Council Panel on Commerce and Industry 2016 Policy Address Policy Initiatives of Innovation and Technology Bureau Background Technological developments, apart

More information

Leti Introduction and Overview

Leti Introduction and Overview Leti Introduction and Overview Leti Day in Tokyo, October 3rd 2012 Laurent Malier 2012 Leti 2012 1 CEA The CEA at a glance Commissariat à l Énergie Atomique et aux Énergies Alternatives is one of the largest

More information

INVENTORY OF GOOD PRACTICES ON OPEN INNOVATION Aalto Design Factory. Helsinki, Finland

INVENTORY OF GOOD PRACTICES ON OPEN INNOVATION Aalto Design Factory. Helsinki, Finland INVENTORY OF GOOD PRACTICES ON OPEN INNOVATION Aalto Design Factory Helsinki, Finland Table of contents 1. Good Practice Profile... 3 2. Good Practice General Description... 7 3. Good Practice Analysis...

More information

Valentina Gualato, Ph.D. Process Development Scientist

Valentina Gualato, Ph.D. Process Development Scientist COMPANY PRESENTATION Quality and Innovation Valentina Gualato, Ph.D. Process Development Scientist MISSION areta international is a biotech company dedicated to the contract development and manufacturing

More information

Clinical Trial Operations

Clinical Trial Operations Contract Research and Consulting Organisation Consulting Clinical Trial Operations Training Your partner for CLINically remarkable results We are a leading Polish company specializing in clinical research

More information

GSK in Singapore. More than 40 years of partnership in Asia

GSK in Singapore. More than 40 years of partnership in Asia GSK in Singapore More than 40 years of partnership in Asia From a single antibiotic plant in 1972, GSK now has extensive activities in Singapore spanning manufacturing to commercial operations. Today this

More information

SACKLER SCHOOL OF GRADUATE BIOMEDICAL SCIENCES CATALOG 2015-2016 PROGRAMS OF STUDY, COURSES AND REQUIREMENTS FOR ALL GRADUATE PROGRAMS

SACKLER SCHOOL OF GRADUATE BIOMEDICAL SCIENCES CATALOG 2015-2016 PROGRAMS OF STUDY, COURSES AND REQUIREMENTS FOR ALL GRADUATE PROGRAMS SACKLER SCHOOL OF GRADUATE BIOMEDICAL SCIENCES CATALOG 2015-2016 PROGRAMS OF STUDY, COURSES AND REQUIREMENTS FOR ALL GRADUATE PROGRAMS Graduate Programs CELL, MOLECULAR, AND DEVELOPMENTAL BIOLOGY CLINICAL

More information

Introduction to the structure of the OIE, Terrestrial Codes and Manuals

Introduction to the structure of the OIE, Terrestrial Codes and Manuals Introduction to the structure of the OIE, Terrestrial Codes and Manuals Training workshop on OIE standards for collection and shipping of pathological specimens Nairobi, KENYA 9-11 August 2011 1 THE OIE

More information